- Home
- SLNO vs SKT Comparison
SLNO vs SKT Comparison
Compare SLNO & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLNO
- SKT
- Stock Information
- Founded
- SLNO 1999
- SKT 1981
- Country
- SLNO United States
- SKT United States
- Employees
- SLNO N/A
- SKT N/A
- Industry
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- SKT Real Estate Investment Trusts
- Sector
- SLNO Health Care
- SKT Real Estate
- Exchange
- SLNO Nasdaq
- SKT Nasdaq
- Market Cap
- SLNO 3.8B
- SKT 3.9B
- IPO Year
- SLNO 2014
- SKT 1993
- Fundamental
- Price
- SLNO $65.46
- SKT $32.66
- Analyst Decision
- SLNO Strong Buy
- SKT Buy
- Analyst Count
- SLNO 9
- SKT 9
- Target Price
- SLNO $116.78
- SKT $37.00
- AVG Volume (30 Days)
- SLNO 1.7M
- SKT 802.7K
- Earning Date
- SLNO 11-05-2025
- SKT 11-04-2025
- Dividend Yield
- SLNO N/A
- SKT 3.58%
- EPS Growth
- SLNO N/A
- SKT N/A
- EPS
- SLNO N/A
- SKT 0.88
- Revenue
- SLNO $32,656,999.00
- SKT $561,024,000.00
- Revenue This Year
- SLNO N/A
- SKT $2.56
- Revenue Next Year
- SLNO $182.29
- SKT $4.65
- P/E Ratio
- SLNO N/A
- SKT $37.17
- Revenue Growth
- SLNO N/A
- SKT 10.60
- 52 Week Low
- SLNO $41.50
- SKT $28.69
- 52 Week High
- SLNO $90.32
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- SLNO 51.66
- SKT 46.23
- Support Level
- SLNO $63.02
- SKT $31.81
- Resistance Level
- SLNO $72.88
- SKT $33.08
- Average True Range (ATR)
- SLNO 4.25
- SKT 0.66
- MACD
- SLNO 1.03
- SKT -0.12
- Stochastic Oscillator
- SLNO 56.61
- SKT 32.84
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.